Strain Profile

Full Cannabinoid Analysis

Total Cannabinoids: 19.30%
Total THC: 17.25%
Total CBD: 0.32%
THCA: 19.33%
Delta-9 THC: 0.30%
CBD: 0.32%
CBG: 0.42%
CBN: ND
CBGA: 0.52%

Key Attributes

Genetic Heritage: Blueberry × [Unknown]
Aroma & Flavor: Sweet berries, fresh citrus, cool mint undertones

Dominant Effects

Relaxing
Euphoric

Potential Benefits

Based on user reports, Blizzard Berry may offer the following potential benefits:

Stress reduction
Sleep support
Pain relief
Muscle relaxation
Evening anxiety management

Please note that these are not medical claims and should not replace professional medical advice!

Terpene Highlights

Blizzard Berry features a rich terpene profile dominated by myrcene, which contributes to its relaxing effects, alongside limonene offering subtle mood elevation, and caryophyllene potentially providing anti-inflammatory benefits. This combination creates the strain’s distinctive berry-forward aroma with cool, refreshing undertones.

User Experience

Disclaimer: THC & Hemp affects individuals differently. Factors such as body chemistry, tolerance, dosage, and consumption method can influence your personal experience. The following description represents a general consensus, but your individual experience may vary.

Blizzard Berry delivers a tranquil experience that begins with a gentle cerebral uplift before transitioning into a deep, soothing body relaxation. The initial effects provide a subtle mental clarity and mild euphoria that gradually melts into a profound sense of physical comfort. As the experience progresses, users often report a pleasant heaviness in the limbs and a serene mental state that makes this strain perfect for evening use. The berry-sweet flavor profile enhances the experience, making Blizzard Berry a treat for both the palate and the senses. With its moderate-high THC content of 17.25%, this indica offers potent relief without overwhelming sedation, though higher doses may lead to a more sleep-inducing effect.

Product Details

Sample ID: SD250205-048 (04032)
Analysis Date: Feb 05, 2025